Myung In Pharmaceutical LTD. (KRX:317450)
South Korea flag South Korea · Delayed Price · Currency is KRW
56,900
+600 (1.07%)
At close: Apr 8, 2026

KRX:317450 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
31,79232,89734,44918,25152,967
Short-Term Investments
477,901227,399153,080124,43467,786
Cash & Short-Term Investments
509,692260,296187,529142,686120,753
Cash Growth
95.81%38.80%31.43%18.16%70.83%
Accounts Receivable
63,65160,77158,14756,78356,688
Other Receivables
5,0553,4923,7112,7102,138
Receivables
68,87064,43362,02059,64659,033
Inventory
64,10860,34356,27747,88046,732
Prepaid Expenses
538.02510.71434.13533.52243.22
Other Current Assets
100.97225.491,32972.68176.49
Total Current Assets
643,309385,809307,589250,818226,938
Property, Plant & Equipment
118,51399,25999,309103,706110,187
Long-Term Investments
10,21910,78328,60824,2426,804
Other Intangible Assets
5,520713.02710.9711.01711.69
Long-Term Accounts Receivable
1,9242,2312,0392,3002,545
Long-Term Deferred Tax Assets
----4.51
Other Long-Term Assets
61,94382,71783,11989,52882,344
Total Assets
841,675581,692521,590471,556429,760
Accounts Payable
6,3018,2982,3972,1292,245
Accrued Expenses
1,2071,3271,4251,2962,290
Current Portion of Leases
1,1751,5281,7271,7391,329
Current Income Taxes Payable
11,45812,38912,94911,47213,494
Current Unearned Revenue
17.32----
Other Current Liabilities
26,02621,05920,68618,45820,374
Total Current Liabilities
46,18444,60239,18435,09339,732
Long-Term Leases
211.161,1722,1603,2064,281
Long-Term Unearned Revenue
7.2970.23115.85161.47-
Pension & Post-Retirement Benefits
----668.61
Long-Term Deferred Tax Liabilities
1.661,4395,3276,6846,605
Other Long-Term Liabilities
892.392,5892,4892,4322,382
Total Liabilities
47,29749,87149,27647,57753,668
Common Stock
7,3005,6005,6005,6005,600
Additional Paid-In Capital
192,082----
Retained Earnings
602,371533,269471,701421,245373,297
Comprehensive Income & Other
-7,375-7,049-4,988-2,866-2,805
Shareholders' Equity
794,378531,821472,314423,979376,092
Total Liabilities & Equity
841,675581,692521,590471,556429,760
Total Debt
1,3862,7003,8874,9455,609
Net Cash (Debt)
508,306257,596183,642137,740115,143
Net Cash Growth
97.33%40.27%33.32%19.63%80.64%
Net Cash Per Share
41932.7022998.4816396.6212298.2510280.65
Filing Date Shares Outstanding
14.6311.211.211.211.2
Total Common Shares Outstanding
14.6311.211.211.211.2
Working Capital
597,125341,207268,406215,724187,206
Book Value Per Share
54305.3047483.9842170.8937855.2833579.64
Tangible Book Value
788,858531,108471,603423,268375,380
Tangible Book Value Per Share
53927.9547420.3142107.4137791.8033516.10
Land
39,46639,46739,08937,09836,955
Buildings
59,27359,17959,29159,02058,923
Machinery
98,43095,86590,30487,40385,970
Construction In Progress
30,9165,2361,374258.5286.44
Source: S&P Global Market Intelligence. Standard template. Financial Sources.